CRIS Current Research Information System

PARCHI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.923
AS - Asia 13.223
EU - Europa 9.281
SA - Sud America 922
AF - Africa 602
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 37.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.677
SG - Singapore 3.568
VN - Vietnam 3.270
CN - Cina 3.199
GB - Regno Unito 2.312
IT - Italia 2.148
DE - Germania 1.190
HK - Hong Kong 1.008
SE - Svezia 663
BR - Brasile 652
FR - Francia 632
IN - India 582
UA - Ucraina 444
RU - Federazione Russa 442
KR - Corea 344
IE - Irlanda 333
NL - Olanda 331
BD - Bangladesh 325
JP - Giappone 249
FI - Finlandia 191
SC - Seychelles 174
ZA - Sudafrica 170
EE - Estonia 137
CA - Canada 130
CI - Costa d'Avorio 118
ID - Indonesia 114
AR - Argentina 107
JO - Giordania 80
MX - Messico 78
PH - Filippine 74
AT - Austria 67
IQ - Iraq 66
BG - Bulgaria 62
TR - Turchia 59
TH - Thailandia 56
CH - Svizzera 53
ES - Italia 49
EC - Ecuador 44
TG - Togo 42
BE - Belgio 39
DK - Danimarca 39
PL - Polonia 35
CO - Colombia 33
TW - Taiwan 31
PK - Pakistan 25
UZ - Uzbekistan 25
SA - Arabia Saudita 24
AU - Australia 22
CL - Cile 20
VE - Venezuela 20
NG - Nigeria 19
GR - Grecia 18
PY - Paraguay 17
LT - Lituania 16
MY - Malesia 16
LB - Libano 15
MA - Marocco 15
IL - Israele 14
TN - Tunisia 14
CZ - Repubblica Ceca 13
IR - Iran 12
PE - Perù 12
EG - Egitto 11
UY - Uruguay 10
DZ - Algeria 9
KE - Kenya 9
AL - Albania 8
AZ - Azerbaigian 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
MD - Moldavia 7
RO - Romania 7
OM - Oman 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
KZ - Kazakistan 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
GA - Gabon 4
HN - Honduras 4
HR - Croazia 4
JM - Giamaica 4
KH - Cambogia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
MN - Mongolia 3
NO - Norvegia 3
NP - Nepal 3
Totale 37.926
Salva come PNG Salva come JPEG
Città #
Singapore 2.470
Southend 1.986
Ashburn 1.398
Fairfield 1.227
Hong Kong 964
Chandler 795
Hefei 747
San Jose 678
Ho Chi Minh City 665
Woodbridge 615
Houston 613
Seattle 601
Dong Ket 580
Hanoi 554
Wilmington 548
Ann Arbor 522
Cambridge 469
Bologna 451
Princeton 424
Beijing 347
Santa Clara 347
Boardman 337
Dublin 333
Council Bluffs 319
Dallas 317
Seoul 300
Jacksonville 270
Lauterbourg 266
Los Angeles 224
Tokyo 204
Nanjing 177
Westminster 172
Berlin 157
New York 154
Milan 139
Padova 138
Turin 136
Redmond 134
Buffalo 130
Helsinki 128
Abidjan 118
Redondo Beach 99
Florence 98
Haiphong 97
Da Nang 93
Jinan 87
Shenyang 85
San Diego 83
Bengaluru 82
Frankfurt am Main 81
Amman 80
Rome 74
Guangzhou 73
São Paulo 73
Chicago 71
Changsha 67
Jakarta 65
Saint Petersburg 65
Des Moines 59
Sofia 57
Tianjin 56
Medford 55
Nuremberg 55
Shanghai 54
Hebei 52
Nanchang 52
Lappeenranta 50
Mülheim 49
Phoenix 48
London 45
Verona 43
Lomé 42
Falls Church 41
Can Tho 39
Olalla 39
Brussels 37
Imola 37
Vienna 37
Amsterdam 35
Montreal 35
Hangzhou 33
San Francisco 33
Toronto 32
Biên Hòa 31
Mexico City 31
Dearborn 30
Jiaxing 30
Zhengzhou 30
Bern 27
Rimini 27
Yubileyny 27
Mahé 26
Hải Dương 25
Norwalk 25
Taiyuan 25
Atlanta 24
Baghdad 24
Copenhagen 24
Orem 23
Redwood City 23
Totale 24.094
Salva come PNG Salva come JPEG
Nome #
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 519
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 416
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 358
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 296
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 287
Messenger RNA processing is altered in autosomal dominant leukodystrophy 280
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 269
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 266
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 252
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 245
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 244
A case of fatal familial insomnia in Africa. 243
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 237
A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder. 233
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 226
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 225
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 225
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 223
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 223
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 222
Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients. 217
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 209
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 209
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 208
Age at onset in genetic prion disease and the design of preventive clinical trials 206
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 204
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 200
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 200
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 197
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 196
Clinical effects of Lewy body pathology in cognitively impaired individuals 195
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 195
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 195
Coexistence of Both PrPSc Type 1 and 2 in sCJD: Does it Affect the Phenotype? 193
Quantifying prion disease penetrance using large population control cohorts 191
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 191
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 190
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 189
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 187
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 186
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 186
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 186
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 183
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 182
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 182
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 181
Sporadic Creutzfeldt-Jakob Disease. 181
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 179
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 176
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 176
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 175
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 174
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 174
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 173
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 173
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 173
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 173
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 172
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 172
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 172
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 171
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 171
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 171
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 168
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease 168
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 167
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 167
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 166
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. 165
Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. 165
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 164
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 163
Transmission properties of atypical Creutzfeldt-Jakob disease: A clue to disease etiology? 162
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 161
Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum 161
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 161
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 161
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 160
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 160
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 159
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 159
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 158
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 158
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 157
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 157
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 157
Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression 157
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 157
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 156
Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study 155
CSF SerpinA1 in Creutzfeldt–Jakob disease and frontotemporal lobar degeneration 155
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 155
Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar cortex. 154
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 153
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 153
Analysis of polymorphisms in PRNP 5' UTR region in sCJD subtypres 153
Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. 153
Agrypnia Excitata 153
Prion disease: an in vivo proton magnetic resonance spectroscopy study of thalamus. 152
Totale 19.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.801
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.071 0 0 0 0 0 0 0 0 0 0 0 1.071
2021/20223.709 348 137 248 179 347 209 86 354 177 309 729 586
2022/20233.873 430 489 161 486 284 284 141 217 679 100 392 210
2023/20241.223 74 185 109 131 131 142 54 112 47 103 75 60
2024/20255.048 207 793 376 361 625 264 386 127 113 416 230 1.150
2025/202614.644 1.256 1.598 1.531 1.118 1.469 748 1.400 587 2.415 1.151 815 556
Totale 38.782